ESR1 and irritable bowel syndrome: Studies have demonstrated upregulation of the expression of ERα in the intestinal mucosa of patients with irritable bowel syndrome, resulting in the dysregulation of estrogen-mediated local immune responses, which may be related to the pathogenesis of irritable bowel syndrome [41].